DFCM
JAZZ icon

Dark Forest Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Dark Forest Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,472
Closed -$1.22M – 910
2026
Q1 		$1.22M Buy
6,472
+4,537
+234% +$793K 0.11% 307
2025
Q4 		$329K Sell
1,935
-9,605
-83% -$1.47M 0.02% 870
2025
Q3 		$1.52M Sell
11,540
-13,933
-55% -$1.67M 0.06% 575
2025
Q2 		$2.7M Buy
+25,473
New +$2.77M 0.11% 312
2023
Q1 		– Sell
-51
Closed -$8.13K – 1328
2022
Q4 		$8.13K Sell
51
-50
-50% -$7.33K ﹤0.01% 785
2022
Q3 		$13K Buy
101
+82
+432% +$12.5K ﹤0.01% 695
2022
Q2 		$3K Sell
19
-35
-65% -$5.39K ﹤0.01% 692
2022
Q1 		$8K Buy
+54
New +$7.84K ﹤0.01% 1036
2021
Q4 		– Sell
-171
Closed -$22K – 1602
2021
Q3 		$22K Buy
+171
New +$25.8K 0.01% 787

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dark Forest Capital Management's JAZZ Position: Q2 2026 in Review

Dark Forest Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 6,472 shares — an estimated $1.22M sold.

Dark Forest Capital Management first reported a position in JAZZ in Q3 2021 and held it in 9 quarters. The position peaked at $2.7M in Q2 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Dark Forest Capital Management reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 6,472 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.22M.
  • Dark Forest Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2021 and held it in 9 quarters.
  • Dark Forest Capital Management's Jazz Pharmaceuticals position peaked at $2.7M in Q2 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.